13.8(top 1%)
impact factor
24.4K(top 1%)
papers
1.2M(top 1%)
citations
373(top 1%)
h-index
14.3(top 1%)
impact factor
26.5K
all documents
1.2M
doc citations
547(top 1%)
g-index

Top Articles

#TitleJournalYearCitations
1Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensusGut20134,813
2Global patterns and trends in colorectal cancer incidence and mortalityGut20173,497
3The risk of colorectal cancer in ulcerative colitis: a meta-analysisGut20012,433
4The Montreal classification of inflammatory bowel disease: controversies, consensus, and implicationsGut20062,362
5Short chain fatty acids in human large intestine, portal, hepatic and venous blood.Gut19872,348
6Management ofHelicobacter pyloriinfection—the Maastricht V/Florence Consensus ReportGut20172,245
7Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeabilityGut20092,061
8Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus ReportGut20122,023
9Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classificationGut19991,959
10Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approachGut20061,931
11The Vienna classification of gastrointestinal epithelial neoplasiaGut20001,838
12The gut microbiota and host health: a new clinical frontierGut20161,719
13Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus ReportGut20071,706
14Epidemiology of gastro-oesophageal reflux disease: a systematic reviewGut20051,522
15Update on the epidemiology of gastro-oesophageal reflux disease: a systematic reviewGut20141,444
16Increased expression of interleukin 17 in inflammatory bowel diseaseGut20031,436
17Endoscopic mucosal resection for treatment of early gastric cancerGut20011,379
18Akkermansia muciniphilaand improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecologyGut20161,379
19A decrease of the butyrate-producing speciesRoseburia hominisandFaecalibacterium prausnitziidefines dysbiosis in patients with ulcerative colitisGut20141,353
20British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adultsGut20191,353
21The Oslo definitions for coeliac disease and related termsGut20131,300
22Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trialGut20121,295
23Functional bowel disorders and functional abdominal painGut19991,294
24An increase in theAkkermansiaspp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese miceGut20141,288
25Kyoto global consensus report onHelicobacter pylorigastritisGut20151,256
26Hepatocellular carcinoma: clinical frontiers and perspectivesGut20141,180
27Prospective comparison of faecal incontinence grading systemsGut19991,157
28Risk assessment after acute upper gastrointestinal haemorrhage.Gut19961,145
29Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man.Gut19801,134
30Guidelines for the management of inflammatory bowel disease in adultsGut20111,127
31British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagusGut20141,116
32Global incidence of oesophageal cancer by histological subtype in 2012Gut20151,110
33High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolomeGut20161,092
34Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel diseaseGut20041,073
35Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective studyGut20061,063
36Butyrate inhibits inflammatory responses through NFkappa B inhibition: implications for Crohn's diseaseGut20001,060
37A simple clinical colitis activity indexGut19981,054
38Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptomsGut20201,044
39Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazineGut20041,012
40Measurement of gastrointestinal pH profiles in normal ambulant human subjects.Gut19881,008
41Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's diseaseGut20071,005
42Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)Gut20101,000
43Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screeningGut2009999
44Modern diagnosis of GERD: the Lyon ConsensusGut2018991
45Exercise and associated dietary extremes impact on gut microbial diversityGut2014987
46Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndromeGut2000977
47Human gut microbiome: hopes, threats and promisesGut2018957
48Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adultsGut2015950
49Fungal microbiota dysbiosis in IBDGut2017939
50Short chain fatty acids in the human colon.Gut1981929